Hello and welcome to the details of J&J, AstraZeneca explore Covid-19 vaccine modification after blood clot reports, says WSJ and now with the details
NEW YORK, July 13 — Johnson & Johnson and AstraZeneca are conducting early research into whether modifications to their Covid-19 vaccines could eliminate or reduce the risk of rare blood clots linked to the shots, the Wall Street Journal reported, citing people close to the process.
WSJ today reported that outside scientists and AstraZeneca’s partner, the University of Oxford, were also involved in the efforts.
AstraZeneca and J&J did not immediately respond to Reuters’ request for comment.
Both vaccines have been linked to the risk of blood clots, though regulators have said that benefits of the vaccines largely outweigh the risks. — Reuters
These were the details of the news J&J, AstraZeneca explore Covid-19 vaccine modification after blood clot reports, says WSJ for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.